| A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors (NCT06115642) | Shanghai Henlius Biotech | 2023-11-24 |
| Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose (NCT06092788) | ATXA Therapeutics Limited | 2023-11-24 |
| Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration (NCT06281860) | Dr Jean Yannis PERENTES | 2023-11-24 |
| Study of Pharmacokinetics and Metabolism on [(14)C]ADC189 (NCT06360796) | Jiaxing AnDiCon Biotech Co.,Ltd | 2023-11-24 |
| A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors (NCT06057038) | Genmab | 2023-11-24 |
| Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 (NCT06164431) | Guangdong Raynovent Biotech Co., Ltd | 2023-11-23 |
| Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis (NCT05974579) | Université de Sherbrooke | 2023-11-23 |
| A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers (NCT06122194) | Pfizer | 2023-11-23 |
| A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants (NCT06294301) | Longbio Pharma | 2023-11-23 |
| Study of NAV-240 in Healthy Volunteers (NCT06181786) | Navigator Medicines, Inc. | 2023-11-22 |
| Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations (NCT06160752) | Tyra Biosciences, Inc | 2023-11-22 |
| BCG for Therapeutic Use Phase I Clinical Trial (NCT06100653) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2023-11-22 |
| A Study of Subcutaneous Gefurulimab Using Prefilled Syringe Versus Autoinjector in Healthy Adult Participants (NCT06208488) | Alexion Pharmaceuticals, Inc. | 2023-11-22 |
| PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer (NCT06173349) | University of California, Davis | 2023-11-22 |
| A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers (NCT06181760) | Island Pharmaceuticals | 2023-11-22 |
| Bioequivalence Study of Perampanel Tablets 10 mg (NCT06450236) | Humanis Saglık Anonim Sirketi | 2023-11-22 |
| A Clinical Study of MK-7962 in Healthy Chinese Participants (MK-7962-021) (NCT06843460) | Merck Sharp & Dohme LLC | 2023-11-22 |
| A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (NCT06145178) | SpyBiotech Limited | 2023-11-22 |
| A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants (NCT06212804) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2023-11-21 |
| Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia (NCT06111027) | University of Minnesota | 2023-11-21 |
| Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma (NCT05312801) | Luminary Therapeutics | 2023-11-21 |
| Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery (NCT06457100) | The Second People's Hospital of Huai'an | 2023-11-21 |
| A Study of ZT002 Injection in Participants With Overweight or Obesity (NCT06371326) | Beijing QL Biopharmaceutical Co.,Ltd | 2023-11-21 |
| Bioequivalence Study of Bilastine Tablets in Healthy Chinese Subjects (NCT06098261) | The Affiliated Hospital of Qingdao University | 2023-11-21 |
| A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014) (NCT06052566) | Merck Sharp & Dohme LLC | 2023-11-21 |
| A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379 (NCT06204107) | Chong Kun Dang Pharmaceutical | 2023-11-21 |
| Study to Evaluate the AIO-001 in Healthy Participants (NCT06170827) | Syneos Health | 2023-11-21 |
| Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease (NCT06189963) | NKGen Biotech, Inc. | 2023-11-21 |
| A Clinical Study of TQH2929 in Healthy Adult Subjects (NCT06156280) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-11-21 |
| A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis (NCT07103369) | SinoMab BioScience Ltd | 2023-11-21 |
| A Study of MK-2225 in Healthy Participants (MK-2225-003) (NCT06643390) | Merck Sharp & Dohme LLC | 2023-11-21 |
| Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases (NCT06078813) | Cancer Trials Ireland | 2023-11-21 |
| Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer (NCT05743621) | Weill Medical College of Cornell University | 2023-11-20 |
| A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3) (NCT06035497) | Bristol-Myers Squibb | 2023-11-20 |
| Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML (NCT05716009) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-11-20 |
| Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects (NCT06475872) | Hanlim Pharm. Co., Ltd. | 2023-11-20 |
| Dose-finding PKPD Trial for RE02 in Healthy Subjects (NCT05979727) | Reconnect Labs | 2023-11-20 |
| A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors (NCT06131840) | Seagen, a wholly owned subsidiary of Pfizer | 2023-11-20 |
| Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects (NCT06063291) | IlDong Pharmaceutical Co Ltd | 2023-11-20 |
| A Study to Compare the Bioavailability of Intravenously Infused Risankizumab Manufactured by Two Different Processes in Healthy Adults (NCT06054425) | AbbVie | 2023-11-20 |
| A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men (NCT07314320) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2023-11-20 |
| Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1) (NCT06300476) | West China Hospital | 2023-11-20 |
| Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER) (NCT06557525) | UNB Sumiyoshi Jinja Mae Clinic | 2023-11-20 |
| Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia (NCT06629376) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2023-11-20 |
| A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants (NCT06138795) | AstraZeneca | 2023-11-20 |
| Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older (NCT06678607) | Reinovax Biologics Co., LTD | 2023-11-19 |
| A Phase 1a Study of PMN310 In Healthy Volunteers (NCT06105528) | ProMis Neurosciences, Inc | 2023-11-18 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the rSm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar (NCT05762393) | International Vaccine Institute | 2023-11-17 |
| Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases (NCT05789589) | Baptist Health South Florida | 2023-11-17 |
| Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose (NCT05809271) | University Hospital, Basel, Switzerland | 2023-11-17 |
| A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension (NCT06137742) | Pfizer | 2023-11-17 |
| A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma (NCT05808608) | Hao Zeng | 2023-11-17 |
| Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI) (NCT06144255) | Florian Schmitzberger | 2023-11-17 |
| Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma (NCT06353152) | Peking University | 2023-11-17 |
| Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers (NCT06141889) | BioAge Labs, Inc. | 2023-11-17 |
| Bioequivalence and Food Effect Bioavailability Study of Lumacaftor Film-Coated Tablets (NCT05968612) | Qanatpharma Canada LTD | 2023-11-17 |
| A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus (NCT06132126) | Eli Lilly and Company | 2023-11-17 |
| A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma (NCT06104553) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-11-17 |
| A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults (NCT06137729) | Pfizer | 2023-11-17 |
| A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer (NCT06115902) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-11-17 |
| A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants (NCT06097702) | Bilix Co.,Ltd. | 2023-11-17 |
| The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects (NCT06148389) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2023-11-16 |
| Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab (NCT06125106) | Zhejiang University | 2023-11-16 |
| A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL) (NCT06173518) | Autolus Limited | 2023-11-16 |
| A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants (NCT06086886) | Bristol-Myers Squibb | 2023-11-16 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS (NCT06143527) | The Foundation for Orthopaedics and Regenerative Medicine | 2023-11-16 |
| Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant. (NCT06139991) | AstraZeneca | 2023-11-16 |
| Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NCT06091943) | BeiGene | 2023-11-16 |
| FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101) (NCT05950334) | Fate Therapeutics | 2023-11-16 |
| NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor (NCT06134960) | Peking University | 2023-11-16 |
| Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants (NCT06106334) | Shionogi | 2023-11-15 |
| Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD) (NCT05643729) | ZEO ScientifiX, Inc. | 2023-11-15 |
| ATI-2231 in Advanced Solid Tumor Malignancies (NCT05791474) | Washington University School of Medicine | 2023-11-15 |
| Gene Therapy for DME (NCT06492876) | Frontera Therapeutics | 2023-11-15 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants (NCT06115967) | AstraZeneca | 2023-11-15 |
| IMM60 and Pembrolizumab in Melanoma and NSCLC (NCT05709821) | iOx Therapeutics | 2023-11-15 |
| A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) (NCT06104449) | Merck Sharp & Dohme LLC | 2023-11-14 |
| A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT05923008) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-11-14 |
| A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma (NCT05583617) | Hoffmann-La Roche | 2023-11-14 |
| A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1) (NCT06186492) | Wave Life Sciences USA, Inc. | 2023-11-14 |
| An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors (NCT05976334) | Takeda | 2023-11-14 |
| Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors (NCT06128551) | Revolution Medicines, Inc. | 2023-11-14 |
| A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors (NCT05983133) | Seagen, a wholly owned subsidiary of Pfizer | 2023-11-14 |
| FIH XON7 in Advanced/Metastatic Solid Tumors (NCT06154291) | Xenothera SAS | 2023-11-14 |
| HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies (NCT05658640) | Princess Maxima Center for Pediatric Oncology | 2023-11-14 |
| Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes (NCT05918055) | National Cancer Institute (NCI) | 2023-11-14 |
| [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer (NCT05870579) | Novartis Pharmaceuticals | 2023-11-13 |
| Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma (NCT05784012) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2023-11-13 |
| Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma (NCT06246162) | Affiliated Hospital of Nantong University | 2023-11-13 |
| A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria (NCT06069544) | BioNTech SE | 2023-11-13 |
| LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours. (NCT06193902) | Leucid Bio | 2023-11-13 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese (NCT06132841) | AstraZeneca | 2023-11-13 |
| A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 (NCT06110923) | Chong Kun Dang Pharmaceutical | 2023-11-13 |
| Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) (NCT06068868) | AbbVie | 2023-11-13 |
| A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults. (NCT06133270) | Novo Nordisk A/S | 2023-11-13 |
| TmCD19-IL18 in CD19+ Cancers (NCT05989204) | University of Pennsylvania | 2023-11-13 |
| Study of HS-10384 in Participants of Chinese Postmenopausal Women (NCT06122181) | Hansoh BioMedical R&D Company | 2023-11-12 |
| Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer (NCT05806814) | University of Oklahoma | 2023-11-12 |
| A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin (NCT06081166) | NewAmsterdam Pharma | 2023-11-11 |
| Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma (NCT06132711) | Xuzhou Medical University | 2023-11-10 |